Skip to main content

Table 2 Operating finding and complication

From: Isoperistaltic versus antiperistaltic uncut Roux-en-Y anastomosis after distal gastrectomy for gastric cancer: a propensity score matched analysis

  ANTI (n = 183) ISO (n = 183) P
n % n %
Mean operation time, mean ± SD, min 251.5 ± 46.4 263.1 ± 46.8 0.735
Mean blood loss, mean ± SD, ml 239.6 ± 32.4 222.5 ± 35.3 0.492
Transfusion 7 3.8 9 4.9 0.617
Harvested lymph node, median (min, max) 29 (17–54)   31 (16–57)   0.565
R0 176 96.2 174 95.1 0.609
Surgery approach
 LAG 90 49.2 76 41.5 0.142
 OG 93 50.8 107 58.5  
Stapler
 Circular 49 26.8 61 33.3 0.171
 Linear 134 73.2 122 66.7  
Occlusion of afferent loop
 Ligation 101 55.2 162 88.5 0.001
 Stapler 82 44.8 21 11.5  
Pathological stage
 Stage 1a 14 7.7 8 4.4 0.868
 Stage 1b 25 13.7 23 12.6  
 Stage 2a 35 19.1 36 19.7  
 Stage 2b 36 19.7 37 20.2  
 Stage 3a 29 15.8 34 18.6  
 Stage 3b 30 16.4 28 15.3  
 Stage 3c 14 7.7 17 9.3  
Postoperative hospital stay, mean ± SD, days 7.7 ± 3.7 8.2 ± 4.3 0.312
Complicationa
 Grade 1 39 37.1 36 34.6 0.792
 Grade 2 30 28.6 32 30.8  
 Grade 3 27 25.7 25 24.0  
 Grade 4 9 8.6 10 9.6  
 Grade 5 0 0.0 1 1.0  
Early-phase complication
 Incision infection 9 4.9 6 3.3 0.306
 Duodenum stump leak 1 0.5 1 0.5 1.000
 Anastomotic leak 1 0.5 0 0.0 1.000
 Anastomotic bleeding 4 2.2 8 4.4 0.244
 Intra-abdominal bleeding 2 1.1 2 1.1 1.000
 Intra-abdominal infection 9 4.9 8 3.8 0.804
 Delayed gastric emptying 1 0.5 2 1.1 0.562
 Pancreatic fistula 10 5.5 5 2.7 0.187
Late-phase complication
 Bowel obstruction 8 4.4 7 3.8 0.792
 Internal hernia 3 1.6 2 1.1 0.652
 Anastomotic stricture 0 0.0 0 0.0 1.000
 Reoperation 2 1.1 2 1.1 1.000
 Mortality in 30 days 0 0.0 1 0.5 1.000
 Adjuvant chemotherapy 129 66.1 134 71.6 0.309
  1. aClavien-Dindo classification